Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • E. coli Uracil-DNA Glycosylase (UDG): Technical Use and Prot

    2026-05-31

    E. coli Uracil-DNA Glycosylase (UDG): Technical Use and Protocols

    What This Product Solves

    Uracil residues can arise in DNA during sample processing, amplification, or storage, leading to compromised data integrity and increased risk of false positives in downstream PCR workflows. E. coli Uracil-DNA Glycosylase (UDG) (SKU K1107) is designed to eliminate uracil-containing DNA contamination by catalyzing the hydrolysis of N-glycosidic bonds between uracil and deoxyribose in both single- and double-stranded DNA. By releasing free uracil, E. coli UDG improves the fidelity of DNA amplification and supports research focused on DNA damage repair and contamination control. This enzyme is not active on RNA and does not function on oligonucleotides shorter than six bases, limiting its use to DNA-centric research workflows.

    For a practical overview of UDG's role in PCR contamination control and DNA repair research, see the Technical Workflow Guide, which details its application boundaries. The Practical Research Guide further clarifies its suitability for research, not clinical, settings.

    Protocol Parameters

    • Enzyme Storage Temperature: -20°C | Essential for maintaining enzyme stability and activity over long-term storage (up to 2 years) | Use for all recombinant UDG enzyme handling | From product information
    • Minimum Oligonucleotide Length: >=6 bases | UDG does not act on oligonucleotides shorter than six bases | Ensure substrates meet this threshold to avoid incomplete uracil excision | From product information
    • Reaction Buffer Concentration: 10X UDG Reaction Buffer supplied | Recommended to dilute to 1X final concentration for standard reactions | Accurate buffer preparation is critical for optimal enzyme activity | From product information
    • Enzyme Unit Application: 1000 U or 5000 U sizes available | Select volume based on sample throughput; adjust units/reaction according to workflow needs | Larger unit sizes support high-throughput or batch processing | From product information and workflow recommendation
    • Substrate Type: DNA only (single- or double-stranded) | Not suitable for RNA substrates | Use exclusively for DNA repair enzyme workflows, avoid RNA or short oligos | From product information

    Workflow Setup and QC Checklist

    To maximize the effectiveness of E. coli UDG in research workflows, adhere to the following setup and quality control steps:

    1. Reagent Preparation: Thaw the enzyme and reaction buffer on ice. Prepare a fresh working dilution of the 10X buffer to 1X immediately before use. Avoid repeated freeze-thaw cycles of the enzyme stock.
    2. Sample Qualification: Confirm that DNA substrates are at least six bases in length and free of RNA contamination. UDG will not excise uracil from shorter oligonucleotides or RNA.
    3. Reaction Assembly: For typical decontamination, combine the DNA sample, diluted UDG reaction buffer, and an appropriate amount of enzyme. Incubate according to downstream workflow requirements (consult published protocols or internal standards for incubation time and temperature).
    4. Negative Controls: Include reactions lacking UDG to monitor background uracil presence and to distinguish enzymatic removal from non-specific degradation.
    5. Post-UDG Treatment: After incubation, proceed to heat inactivation (if required by the application) or direct downstream processing. Confirm uracil excision by relevant analytical methods (e.g., gel electrophoresis or qPCR).
    6. Storage and Documentation: Return unused enzyme and buffer to -20°C immediately after use. Log batch numbers and usage to maintain traceability and QC compliance.

    Common Failure Modes and Fixes

    • Incomplete Uracil Removal: If residual uracil is detected post-treatment, verify that the DNA substrate is at least six bases long and that buffer preparation and incubation parameters are correct. Insufficient enzyme or expired reagents may also cause reduced activity.
    • Loss of Enzyme Activity: Enzyme activity may decrease after multiple freeze-thaw cycles or prolonged exposure to room temperature. Always aliquot enzyme stocks to minimize freeze-thaw and maintain storage at -20°C.
    • Unintended DNA Damage: Over-incubation or improper buffer conditions may lead to nicking or degradation of DNA. Follow established protocols for time and temperature, and conduct pilot reactions to optimize conditions for your specific assay.
    • No Activity Observed: Confirm that the substrate is DNA (not RNA) and that oligonucleotides are of sufficient length. Check reaction buffer composition and rule out inhibitory contaminants (e.g., EDTA, excessive salt).

    Scope and Limitations

    E. coli Uracil-DNA Glycosylase (UDG) is purpose-built for research applications involving uracil excision from DNA, including PCR product contamination elimination and DNA damage repair research. Its specificity excludes activity on RNA and on oligonucleotides shorter than six bases, so it should not be used for applications requiring RNA decontamination or for use on very short DNA fragments. This enzyme is not intended for diagnostic or clinical use, and results should be interpreted within the context of research-only workflows.

    For additional details on workflow parameters and QC, refer to the Workflow Parameters & QC guide.

    Conclusion

    E. coli UDG is a validated DNA repair enzyme for excising uracil from DNA in PCR and related research workflows, enhancing the integrity and fidelity of amplification assays. Provided with a 10X UDG Reaction Buffer and available in convenient unit sizes, this product supports rigorous contamination control in research laboratories. For full product details and ordering, consult E. coli Uracil-DNA Glycosylase (UDG) at APExBIO. Always adhere to storage, handling, and usage guidelines to maintain enzyme performance and ensure reproducible results.